Category Archives: Technology Transfer

On Technology Transfer Metrics, 3: Money

Posted on July 28, 2020 by Gerald Barnett

Universities don’t track their transfers, the federal government does not track university transfers, and professional organizations and nonprofits do not track university transfers. Law firms don’t track university transfers. Venture capital firms don’t track university transfers. Pretty much anyone who … Continue reading →

Posted in Metrics, Technology Transfer | Tagged , , , | Leave a comment

On Technology Transfer Metrics, 2: Management

Posted on July 26, 2020 by Gerald Barnett

There are uses for metrics in business. One is to make management decisions. There’s a repeated bit of nonsense–you can’t manage what you don’t measure. There’s a veneer in truth in that, along the lines of “if you measure it, … Continue reading →

Posted in Metrics, Technology Transfer | Tagged , , | Leave a comment

On Technology Transfer Metrics, 1: Issues

Posted on July 22, 2020 by Gerald Barnett

Let’s follow up on the fact that there’s no publicly available–free–data source to track university to industry technology transfer. There’s no non-free data source to track such transfer, either. You would think there would be. To get at metrics, let’s … Continue reading →

Posted in Metrics, Technology Transfer | Tagged , , , , | Leave a comment

Freely available data resources to track US university technology transfer

Posted on July 15, 2020 by Gerald Barnett

I answered a Quora question. Here it is. Are there any freely available data resources to track technology transfer activity between universities and commercial businesses in the US? Here’s my answer. No. And that’s quite amazing. Most universities publish an … Continue reading →

Posted in Technology Transfer | Tagged , , , , | Leave a comment

Mick Stadler writes a letter in 1976 on “effective transfer mechanisms”–2

Posted on June 19, 2020 by Gerald Barnett

We are working through Mick Stadler’s 1976 letter to Research Corporation’s Willard Marcy. Stadler outlines eight functions for a next generation “technology transfer mechanism.” The essentials of Stadler’s view are that the mechanism must distribute technology widely, must be distributed, … Continue reading →

Posted in Policy, Technology Transfer | Tagged , | 1 Comment

Mick Stadler writes a letter in 1976 on “effective transfer mechanisms”–1

Posted on June 18, 2020 by Gerald Barnett

On June 29, 1976 Mick Stadler wrote a letter to Willard Marcy, the Vice President of Research Corporation’s Patent Program. Stadler, at the time was assistant director of the Case Western Reserve technology transfer program. He would go on to … Continue reading →

Posted in History, Policy, Technology Transfer | Tagged , , | 1 Comment

Harbridge House on university exclusive licensing, 2

Posted on June 16, 2020 by Gerald Barnett

There’s one more thing raised by the Harbridge House report–the metrics on those patent development firms. Patent applications are filed on approximately 10 to 15 percent of the disclosures submitted and, if present circumstances continue, only one-quarter of these patents … Continue reading →

Posted in Commons, History, Policy, Technology Transfer | Tagged , , , | Comments Off on Harbridge House on university exclusive licensing, 2

Harbridge House on university exclusive licensing, 1

Posted on June 15, 2020 by Gerald Barnett

The Harbridge House report on government patent policy in 1968 laid the foundation for Bayh-Dole. Or, rather, federal officials selectively used portions of the report to change federal policy to conform to the wishes of patent development firms affiliated with … Continue reading →

Posted in History, Policy, Technology Transfer | Tagged , , | Comments Off on Harbridge House on university exclusive licensing, 1

Bayh-Dole on 200 drugs, 3

Posted on May 22, 2020 by Gerald Barnett

We are working through examples of the claim that Bayh-Dole has led to the creation of 200 new drugs. There’s been a lot of post hoc fallaciphizing–that because Bayh-Dole came before some of these new drugs, they must have come … Continue reading →

Posted in Bayh-Dole, high priced drugs, Technology Transfer | Tagged , , | Comments Off on Bayh-Dole on 200 drugs, 3

Why dealing in patent monopolies is bad for university research

Posted on May 19, 2020 by Gerald Barnett

[updated to add some comments among the elements of the list] Bayh-Dole recovers and expands the opportunity for universities to deal in patent monopolies on inventions made in federally supported work. Bayh-Dole does not require such behavior, does not give … Continue reading →

Posted in Bayh-Dole, Commons, Freedom, Technology Transfer | Tagged , , | Comments Off on Why dealing in patent monopolies is bad for university research